Serum TGF-β level in patients with different stages of stable COPD

A. Polivanova, A. Averyanov, A. Chuchalin, K. Zykov (Moscow, Russian Federation)

Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Session: Biomarkers and disease assessment in COPD
Session type: E-Communication Session
Number: 3119
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Polivanova, A. Averyanov, A. Chuchalin, K. Zykov (Moscow, Russian Federation). Serum TGF-β level in patients with different stages of stable COPD. Eur Respir J 2008; 32: Suppl. 52, 3119

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD patients with more severe GOLD stages have higher serum cystatin C levels
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012

The prevalence of low hemoglobin levels in patients with COPD stratified for disease stage
Source: Eur Respir J 2004; 24: Suppl. 48, 63s
Year: 2004

Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Serum levels of IL-6 in adult patients with moderate to severe asthma.
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017


Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
Source: Annual Congress 2013 –COPD treatment
Year: 2013

The role of serum IL6 in stable COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018


Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011

The expression of selected biomarkers at the systemic and local level in patients with COPD
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018

Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001

Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Vip in the serum of asthmatic patients and in COPD patients in stable state and during exacerbation
Source: Eur Respir J 2007; 30: Suppl. 51, 403s
Year: 2007

Serum vitamin D level is associated with emphysema progression in male patients with COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Plasma vitamin D concentration and clinical characteristics in clinically stable patients with moderate COPD
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011


Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005

Predictors of the level of daily activities for different GOLD COPD stages
Source: Eur Respir J 2007; 30: Suppl. 51, 127s
Year: 2007

Relation of low serum lipid levels with coronary atherosclerosi in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 662s
Year: 2006

Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Gender differences in plasma biomarkers levels in patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010


HDL serum levels are significantly lower in patients with COPD than in never-smokers
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017